(NYSE: CBT) Cabot's forecast annual revenue growth rate of 4.38% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.
Cabot's revenue in 2024 is $3,924,000,000.On average, 3 Wall Street analysts forecast CBT's revenue for 2024 to be $224,185,238,430, with the lowest CBT revenue forecast at $219,989,521,698, and the highest CBT revenue forecast at $226,408,952,223. On average, 3 Wall Street analysts forecast CBT's revenue for 2025 to be $238,300,835,024, with the lowest CBT revenue forecast at $229,939,334,143, and the highest CBT revenue forecast at $245,835,198,850.
In 2026, CBT is forecast to generate $248,393,880,424 in revenue, with the lowest revenue forecast at $239,190,719,642 and the highest revenue forecast at $256,699,618,010.